Robert Middleberg

Robert Middleberg was the director of the Pennsylvania toxicology laboratory that analyzed tissue samples from patients who died during Hurricane Katrina. His role in the investigation of deaths at Memorial and LifeCare was to present the laboratory’s findings and help the assembled experts assess what those findings could—and could not—establish. The book identifies him through this work rather than supplying a broader personal biography.

Role in the Investigation

Investigators sent tissue samples from eighteen bodies recovered at Memorial to National Medical Services, Inc., in Willow Grove, Pennsylvania. Later, Middleberg joined a meeting of experts convened to examine the evidence. Virginia Rider and two nurses who had worked with her prepared charts showing the drugs found in each body; Middleberg attended as the laboratory director and presented the test results.

The scope of the inquiry had widened beyond the four deaths on which Anna Pou, Lori Budo, and Cheri Landry had been arrested. Middleberg’s laboratory had analyzed forty-one bodies from Memorial and LifeCare, and twenty-three tested positive for morphine, midazolam, or both. Those results made the toxicology evidence consequential, but they did not by themselves settle how the drugs had been administered or what had caused an individual patient’s death.

Findings and Caution

Middleberg had handled thousands of cases, and the concentrations detected in many of the patients appeared unusually high to him. Yet he emphasized that postmortem tissue toxicology was not as straightforward to interpret as a blood test from a living patient. The bodies had remained in heat before sampling, and decomposition could affect measured concentrations. He therefore urged the group to consider each patient’s clinical history alongside the laboratory numbers.

That caution framed the experts’ case-by-case review. They considered whether a finding might reflect a large dose given shortly before death or repeated doses that accumulated, and whether conditions such as kidney or liver disease could have affected how a patient processed medication. They also asked whether the drugs could suppress breathing in patients not on respirators and whether any proposed effect matched the known timing of death. Middleberg’s approach in the meeting was thus evidentiary and qualified: the laboratory results mattered, but their meaning depended on circumstances the test alone could not supply.

The Limits of Toxicology Evidence

The book places Middleberg’s presentation within a broader disagreement over how to interpret drugs detected in decomposed remains. Some experts stressed that heat and decomposition made it difficult to infer the doses present before death; others argued that uncertainty about dosage did not erase the significance of finding the drugs. Middleberg’s recorded caution supports neither an automatic conclusion of criminal intent nor a dismissal of the results. It instead makes the distinction between detecting a substance and establishing its timing, effect, and causal role central to the inquiry.

His contribution gave investigators a structured basis for comparing the laboratory results with patient records, while leaving disputed questions open for further analysis. The toxicology findings could inform judgments about exposure and possible cause of death, but the meeting’s patient-by-patient method reflected the limits of drawing a single conclusion from postmortem concentrations across many different medical histories.